Over two days in Vienna, the EAN Communication Committee worked on new strategies to engage colleagues, the public, and all those who are part of the home of neurology—and beyond.
As #BrainAwarenessWeek continues, we would like to remind you: train, protect & love your brain. 🧠
📝This month's #EANPOTM explores evobrutinib in relapsing MS.
Two phase 3 trials show it’s not superior to teriflunomide in reducing relapse rates or imaging outcomes. What does this mean for #MS treatment?
🔗Read more on EAN News: https://t.co/7EePGxpzyt
📌🍾Our paper is out🥂Of the many results from the European survey, what strikes me is that 17% of the 47 national neurological societies had NO CONTACTS AT ALL WITH ANY NEUROLOGICAL PATIENTS ASSOCIATIONS of the respective country. So much to do in Europe!EAN is ready to support!
🧠 #EANPOTM: The latest #Lancet Commission report on the prevention of #dementia identifies 14 modifiable risk factors for dementia, including new additions like untreated vision loss and high LDL cholesterol.
💡Early intervention is key!
More info: https://t.co/9glvPezl4G
Our July #EANPOTM explores the link between sleep rhythms and Alzheimer's disease pathology. 🧠💡
Discover how disturbances in 24-hour activity rhythms could impact amyloid-beta accumulation, particularly in APOE4 carriers.
🔗 Learn more: https://t.co/OwLxFSEuV0
"I believe EAN can play a key role in a European scenario full of changes in terms of epidemiological transition, ageing, increase in the burden of NCDs, and neuroscience developments, but also in terms of the fragilities created by medical, political and humanitarian crises."
As we kick off day 2 of #ean2024, we can already reflect on some of the latest news from yesterday's sessions.
Visit https://t.co/Hf2jMPcJVu to catch up on the latest news and reports on some of yesterday's highlights mentioned below!
#ean2024#neurology#congress
#EANPOTM:
New study in @TheLancetNeuro shows the vast impact of neurological disorders globally, now the leading cause of disability & disease.
Over 3.4 billion affected, signaling call for enhanced care & research.
🔗Dive into the findings: https://t.co/AZBhwCT2Yw
Read the highlights from the recent EAN RRFS Representative meeting held in Porto, generously hosted by the Portuguese Neurological Society! 🧠
🔗Article: https://t.co/mdxYXNkb0A
🤝A big thank you to our hosts and passionate participants for making this gathering a success!🎊
If you do not communicate you do not exists.EAN #CommunicationCommittee is a dream team of EU #neurologists leading advocacy&communication of @EANeurology.All committed, enthusiastic to create links between science,research, education,clinics, policy,patients NGOs. #communicaton
Big news for the #MyastheniaGravis community! Two teams, led by Bril and Howard, are making headway with Rozanolixizumab & Zilucoplan. Both treatments showed promise in improving MG symptoms. Research is on the fast track! 🚀 #ClinicalTrials#Rozanolixizumab#Zilucoplan
Prion-like transmission of amyloid-ß through cadaveric dura, decades after neurosurgical procedures, has been hypothesized as an iatrogenic cause of CAA. The most extensive case series to date was recently published in Stroke.
https://t.co/UUIHp3PWxi
È ufficialmente online il primo episodio della nuova stagione di Neuropod, il podcast ufficiale della SIN! 🎧🧠
Ascoltaci dove vuoi, quando vuoi!
#singiovani#neurologia#podcast#giovanineurologi
Our pick for #ResearchPaper of the Month for January is "Intensive blood pressure control after endovascular thrombectomy for acute ischaemic #stroke (ENCHANTED2/MT)".
Follow the 🔗 below to read our summary.
👉https://t.co/WcaZhYE7w6
#research#neurology#scientific
Today first meeting of the new @EANeurology Communication Committee🍀Linking 47 countries, speaking for and to 44.000 European #neurologists and millions of neurological patients. News, science, public health, research, people!The best is still to come!#eanpages#eanweb
Our selected #ResearchPaper of the Month for November is "Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion".
Follow the 🔗 below to read more about the trial and the full results!
👉 https://t.co/5X59mB9V63
#research#neurology#scientific#EANeurology
Berlin, 15-16 october 2022:meeting of the RRFS National and commette representatives of EAN. Two wonderful days with great colleagues and full of new ideas about the future of Neurology in Europe. @EANeurology @v_s_carvalho @LucaCuffaro1@NinaVashchenko@Cheshir77216793